Logo image of HNGE

HINGE HEALTH INC-A (HNGE) Stock Price, Forecast & Analysis

USA - NYSE:HNGE - US4333131039 - Common Stock

41 USD
-1.33 (-3.14%)
Last: 11/13/2025, 1:15:05 PM

HNGE Key Statistics, Chart & Performance

Key Statistics
Market Cap3.22B
Revenue(TTM)390.40M
Net Income(TTM)-11.93M
Shares78.44M
Float23.53M
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.15
PEN/A
Fwd PE35.08
Earnings (Next)N/A N/A
IPO2025-05-22
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services


HNGE short term performance overview.The bars show the price performance of HNGE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20 -25

HNGE long term performance overview.The bars show the price performance of HNGE in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of HNGE is 41 USD. In the past month the price decreased by -16.03%.

HINGE HEALTH INC-A / HNGE Daily stock chart

HNGE Latest News, Press Relases and Analysis

HNGE Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS CVS HEALTH CORP 11.6 100.82B
CI THE CIGNA GROUP 9.68 73.39B
LH LABCORP HOLDINGS INC 16.95 22.29B
DGX QUEST DIAGNOSTICS INC 19.37 21.14B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 112.65 20.35B
GH GUARDANT HEALTH INC N/A 11.79B
DVA DAVITA INC 13.37 8.82B
HIMS HIMS & HERS HEALTH INC 67.89 8.29B
CHE CHEMED CORP 20.41 6.54B
BTSG BRIGHTSPRING HEALTH SERVICES 31.83 5.75B
RDNT RADNET INC 193.03 5.64B
OPCH OPTION CARE HEALTH INC 19.38 4.69B

About HNGE

Company Profile

HNGE logo image Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. The company is headquartered in San Francisco, California and currently employs 1,514 full-time employees. The company went IPO on 2025-05-22. The firm has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. The company offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.

Company Info

HINGE HEALTH INC-A

455 Market Street, Suite 700

San Francisco CALIFORNIA US

Employees: 1514

HNGE Company Website

Phone: 14156898429

HINGE HEALTH INC-A / HNGE FAQ

What does HINGE HEALTH INC-A do?

Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. The company is headquartered in San Francisco, California and currently employs 1,514 full-time employees. The company went IPO on 2025-05-22. The firm has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. The company offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.


What is the current price of HNGE stock?

The current stock price of HNGE is 41 USD. The price decreased by -3.14% in the last trading session.


Does HNGE stock pay dividends?

HNGE does not pay a dividend.


How is the ChartMill rating for HINGE HEALTH INC-A?

HNGE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


How is the market expecting HNGE stock to perform?

21 analysts have analysed HNGE and the average price target is 64.99 USD. This implies a price increase of 58.51% is expected in the next year compared to the current price of 41.


Can you provide the market cap for HINGE HEALTH INC-A?

HINGE HEALTH INC-A (HNGE) has a market capitalization of 3.22B USD. This makes HNGE a Mid Cap stock.


What is the outstanding short interest for HINGE HEALTH INC-A?

The outstanding short interest for HINGE HEALTH INC-A (HNGE) is 8.71% of its float.


HNGE Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to HNGE.


Chartmill TA Rating
Chartmill Setup Rating

HNGE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to HNGE. No worries on liquidiy or solvency for HNGE as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HNGE Financial Highlights

Over the last trailing twelve months HNGE reported a non-GAAP Earnings per Share(EPS) of -0.15. The EPS increased by 88.96% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -1.72%
ROE -3.19%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)88.96%
Revenue 1Y (TTM)33.37%

HNGE Forecast & Estimates

21 analysts have analysed HNGE and the average price target is 64.99 USD. This implies a price increase of 58.51% is expected in the next year compared to the current price of 41.

For the next year, analysts expect an EPS growth of 488.89% and a revenue growth 43.83% for HNGE


Analysts
Analysts82.86
Price Target64.99 (58.51%)
EPS Next Y488.89%
Revenue Next Year43.83%

HNGE Ownership

Ownership
Inst Owners127.07%
Ins Owners8.08%
Short Float %8.71%
Short Ratio2.05